Harnstoff Acis

Harnstoff Acis is a topical dermatological preparation whose active ingredient is urea, a keratolytic agent commonly used in skin care. It is marketed in the European Union and is available over‑the‑counter. The product is applied to the skin to help manage conditions characterized by thickened or dry skin, though specific strength and dosage form are not disclosed.

Harnstoff Acis is indicated for several dermatologic conditions where the skin barrier is compromised or hyperkeratotic. It is used to improve skin texture and reduce scaling.

- Management of hyperkeratosis and callus formation - Adjunct therapy for psoriasis plaques - Treatment of ichthyosis and related scaling disorders - Relief of chronic dry or rough skin - Preparation of skin before topical medication application

Side effects of Harnstoff Acis are generally mild, reflecting its local action on the skin. Most reactions are reversible upon discontinuation.

Common: - Transient stinging or burning sensation at the application site - Mild erythema or redness - Slight itching or pruritus - Dryness or flaking of treated skin - Temporary swelling or edema

Serious: - Allergic contact dermatitis with vesiculation - Severe skin irritation persisting beyond 24 hours - Worsening of existing eczema or dermatitis - Development of urticaria or widespread rash - Signs of infection at the application site

When using Harnstoff Acis, certain precautions help minimize adverse reactions and ensure safe use.

- Perform a patch test on a small skin area before widespread application - Avoid use on broken, inflamed, or infected skin unless directed by a healthcare professional - Do not apply to mucous membranes, eyes, or genital areas - Limit exposure to large surface areas to reduce systemic absorption risk - Discontinue use and seek medical advice if severe irritation or allergic signs develop - Keep out of reach of children; store at room temperature away from direct sunlight

Harnstoff Acis may interact with other topical agents or systemic conditions. Awareness of potential interactions can guide safe co‑administration.

Avoid: - Concurrent use with other strong keratolytics (e.g., high‑strength salicylic acid) without professional guidance - Application over topical corticosteroids or immunosuppressants unless instructed - Use on skin treated with chemical peels or laser therapy without waiting the recommended interval

Use with caution: - Combining with moisturizers containing fragrances or alcohol, which may increase irritation - Applying over occlusive dressings that can enhance drug penetration - Use in patients with known urea hypersensitivity - Co‑application with systemic medications that affect skin healing (e.g., retinoids)